• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰儿科内分泌学和糖尿病学会以及波兰糖尿病儿科分会关于在波兰使用混合闭环系统为儿童和青少年糖尿病患者进行胰岛素治疗的指南。

Guidelines of the Polish Society of Pediatric Endocrinology and Diabetology and Pediatric Section of Diabetes Poland on insulin therapy using hybrid closed-loop systems in children and adolescents with diabetes in Poland.

机构信息

Department of Paediatrics, Diabetology, Endocrinology and Nephrology, Medical University of Lodz, Poland.

Department of Paediatrics, Institute of Medical Sciences, University of Opole, Poland.

出版信息

Pediatr Endocrinol Diabetes Metab. 2024;30(3):132-147. doi: 10.5114/pedm.2024.144041.

DOI:10.5114/pedm.2024.144041
PMID:39451186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11538916/
Abstract

Currently, hybrid closed loop (HCL) systems represent the most advantageous therapeutic option for people with diabetes requiring intensive insulin therapy. They make it possible to achieve optimal metabolic control of the disease in any age group while improving the quality of life of children and adolescents with diabetes and their families. Therefore, we present recommendations for the use of HCL systems in children and adolescents focusing on systems currently available in Poland. These systems should be the first choice in terms of method of insulin therapy in the paediatric population. They can be implemented at any stage of diabetes management. These recommendations are based on scientific evidence and experts' experience. They include principles for the initiation, optimisation, and ongoing management of HCL therapy, as well as the required HCL-related education.

摘要

目前,混合闭环 (HCL) 系统是需要强化胰岛素治疗的糖尿病患者最有利的治疗选择。它们使在任何年龄组都能实现疾病的最佳代谢控制,同时提高糖尿病儿童和青少年及其家庭的生活质量。因此,我们提出了在儿童和青少年中使用 HCL 系统的建议,重点介绍了目前在波兰可用的系统。这些系统应该是儿科人群胰岛素治疗方法的首选。它们可以在糖尿病管理的任何阶段实施。这些建议基于科学证据和专家经验。它们包括启动、优化和持续管理 HCL 治疗的原则,以及所需的 HCL 相关教育。

相似文献

1
Guidelines of the Polish Society of Pediatric Endocrinology and Diabetology and Pediatric Section of Diabetes Poland on insulin therapy using hybrid closed-loop systems in children and adolescents with diabetes in Poland.波兰儿科内分泌学和糖尿病学会以及波兰糖尿病儿科分会关于在波兰使用混合闭环系统为儿童和青少年糖尿病患者进行胰岛素治疗的指南。
Pediatr Endocrinol Diabetes Metab. 2024;30(3):132-147. doi: 10.5114/pedm.2024.144041.
2
Recommendations for recognizing, risk stratifying, treating, and managing children and adolescents with hypoglycemia.儿童和青少年低血糖的识别、风险分层、治疗和管理建议。
Front Endocrinol (Lausanne). 2024 Jun 4;15:1387537. doi: 10.3389/fendo.2024.1387537. eCollection 2024.
3
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.用于管理1型糖尿病患者血糖水平的混合闭环系统:系统评价与经济建模
Health Technol Assess. 2024 Dec;28(80):1-190. doi: 10.3310/JYPL3536.
4
Do hybrid closed loop insulin pump systems improve glycemic control and reduce hospitalizations in poorly controlled type 1 diabetes?混合闭环胰岛素泵系统能否改善血糖控制并减少1型糖尿病控制不佳患者的住院次数?
J Pediatr Endocrinol Metab. 2024 Nov 5;37(12):1028-1035. doi: 10.1515/jpem-2024-0312. Print 2024 Dec 17.
5
Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.6 个月混合闭环胰岛素输送对 1 型糖尿病成人的影响:一项随机对照试验方案。
BMJ Open. 2018 Jun 9;8(6):e020274. doi: 10.1136/bmjopen-2017-020274.
6
Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes.英国国家医疗服务体系(NHS)关于1型糖尿病儿童和青少年血糖结果、血糖达标时间及生活质量的混合闭环真实世界研究的长期评估
BMC Med. 2024 Apr 24;22(1):175. doi: 10.1186/s12916-024-03396-x.
7
Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis.不同混合闭环系统在 1 型糖尿病患者中用于自动胰岛素输送的疗效和安全性:系统评价和网络荟萃分析。
Diabetes Metab Res Rev. 2024 Sep;40(6):e3842. doi: 10.1002/dmrr.3842.
8
One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes.1 型糖尿病患儿和青少年使用混合闭环系统治疗 1 年的经验:取得成功的驱动因素。
Acta Diabetol. 2021 Feb;58(2):207-213. doi: 10.1007/s00592-020-01607-4. Epub 2020 Oct 12.
9
Automated insulin delivery systems in the treatment of diabetes: Benefits, challenges, and practical considerations in pediatric patients.自动胰岛素输送系统在糖尿病治疗中的应用:儿科患者的益处、挑战及实际考量
Endocrinol Diabetes Nutr (Engl Ed). 2024 Dec;71(10):436-446. doi: 10.1016/j.endien.2024.11.010. Epub 2024 Nov 19.
10
Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.1型糖尿病青少年的昼夜混合闭环胰岛素给药:一项自由生活的随机临床试验。
Diabetes Care. 2016 Jul;39(7):1168-74. doi: 10.2337/dc15-2078. Epub 2016 Jan 6.

引用本文的文献

1
The effect of insulin on the central nervous system: insights into neurological complications and management of type 1 diabetes in the pediatric population.胰岛素对中枢神经系统的影响:对儿科1型糖尿病神经并发症及管理的见解。
Pediatr Endocrinol Diabetes Metab. 2025;31(2):68-74. doi: 10.5114/pedm.2025.152597.

本文引用的文献

1
Excellence in the management of Advanced Hybrid Closed-Loop Systems: Lessons from the Polish cohort.高级混合闭环系统管理的卓越表现:波兰队列的经验教训。
Diabetes Res Clin Pract. 2024 Oct;216:111832. doi: 10.1016/j.diabres.2024.111832. Epub 2024 Aug 22.
2
Time In Tight Range in children and adolescents with type 1 diabetes: A cross-sectional observational single centre study evaluating efficacy of new advanced technologies.1 型糖尿病患儿和青少年的时间在狭窄范围内:一项评估新型先进技术疗效的横断面观察性单中心研究。
Diabetes Metab Res Rev. 2024 Jul;40(5):e3826. doi: 10.1002/dmrr.3826.
3
Automated Insulin Delivery Systems in Pediatric Type 1 Diabetes: A Narrative Review.儿科 1 型糖尿病的自动化胰岛素输注系统:叙事性综述。
J Diabetes Sci Technol. 2024 Nov;18(6):1324-1333. doi: 10.1177/19322968241248404. Epub 2024 May 24.
4
Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial.比较 1 型糖尿病孕妇的先进混合闭环治疗与标准胰岛素治疗(CRISTAL):一项平行组、开放标签、随机对照试验。
Lancet Diabetes Endocrinol. 2024 Jun;12(6):390-403. doi: 10.1016/S2213-8587(24)00089-5. Epub 2024 Apr 30.
5
Assessing the feasibility of time in tight range (TITR) targets with advanced hybrid closed loop (AHCL) use in children and adolescents: A single-centre real-world study.评估先进混合闭环 (AHCL) 在儿童和青少年中使用的时间紧范围 (TITR) 目标的可行性:一项单中心真实世界研究。
Diabet Med. 2024 Aug;41(8):e15333. doi: 10.1111/dme.15333. Epub 2024 Apr 26.
6
Twelve-Month Follow-up from a Randomized Controlled Trial of Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents with Type 1 Diabetes Using the MiniMed™ 780G Advanced Hybrid Closed-Loop System.简化餐次告知与精准碳水化合物计数在使用 MiniMedTM 780G 先进混合闭环系统的 1 型糖尿病青少年中 12 个月的随机对照试验随访结果。
Diabetes Technol Ther. 2024 Mar;26(S3):76-83. doi: 10.1089/dia.2023.0429.
7
Celebrating the Data from 100,000 Real-World Users of the MiniMed™ 780G System in Europe, Middle East, and Africa Collected Over 3 Years: From Data to Clinical Evidence.庆祝 MiniMed™ 780G 系统在欧洲、中东和非洲 3 年多时间里收集的 100,000 名真实用户数据:从数据到临床证据。
Diabetes Technol Ther. 2024 Mar;26(S3):32-37. doi: 10.1089/dia.2023.0433.
8
The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review.自动化胰岛素输送系统的健康经济学和时间范围在糖尿病建模中的潜在应用:叙事性综述。
Diabetes Technol Ther. 2024 Mar;26(S3):66-75. doi: 10.1089/dia.2023.0438.
9
Exercising Safely with the MiniMed™ 780G Automated Insulin Delivery System.使用 MiniMed™ 780G 自动胰岛素输送系统安全锻炼。
Diabetes Technol Ther. 2024 Mar;26(S3):84-96. doi: 10.1089/dia.2023.0420.
10
Delayed prandial insulin boluses are an important determinant of blood glucose control and relate to fear of hypoglycemia in people with type 1 diabetes on advanced technologies.延迟餐时胰岛素大剂量注射是血糖控制的重要决定因素,并且与采用先进技术的1型糖尿病患者对低血糖的恐惧有关。
J Diabetes Complications. 2024 Feb;38(2):108689. doi: 10.1016/j.jdiacomp.2024.108689. Epub 2024 Jan 17.